Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer

Seminars in Radiation Oncology

Volumn 10, Issue 4, 2000, Pages 324-332

  Meko, Jennifer ^a   Rusch, Valerie W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; MITOMYCIN; PACLITAXEL; VINBLASTINE; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG INDUCED DISEASE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; REVIEW;

EID: 0033788047     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2000.9128     Document Type: Article

References (48)

1. An investigation into the lymphatic and vascular spread of carcinoma of the bronchus
2. Surgery of the lung
3. Parasternal mediastinoscopy. Assessment of operability in left upper lobe lung cancer: A prospective analysis
4. Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma
5. Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults
6. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group
7. A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma
8. Aggressive surgical intervention in N2 non-small cell cancer of the lung
9. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung
10. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging
11. Mediastinal lymph node staging of non-small cell lung cancer: A prospective comparison of computed tomography and positron emission tomography
12. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases
13. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung
14. Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer?
15. Significance of metastatic disease in subaortic lymph nodes
16. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11
17. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer
18. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma. Results of a North Central Cancer Treatment Group phase III study
19. The role of surgery in N2 lung cancer
20. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
21. The current status of adjuvant chemotherapy for resected non-small cell lung cancer
22. Induction or neoadjuvant therapy in resectable non-small cell lung cancer
23. Combined radiotherapy and resection for carcinoma of the bronchus. Experiences with 66 patients
24. Preoperative x-ray therapy as an adjuvant in the treatment of bronchogenic carcinoma
25. Preoperative radiation therapy in the treatment of bronchial carcinoma
26. Preoperative irradiation of cancer of the lung: Final report of a therapeutic trial. A collaborative study
27. Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
28. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small cell lung cancer: Results of the Toronto phase II trial
29. Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung. LCSG 881
30. Results of Cancer and Leukemia Group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer
31. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
32. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
33. Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis
34. A phase III comparison of 'best local-regional therapy' with or without chemotherapy for stage IIIA, T1-3 N2
35. Comparison of pre-operative thoracic radiation therapy to pre-operative chemotherapy in surgically staged IIIA (N2) non-small cell lung cancer: Initial results of Cancer and Leukemia Group B (CALGB) phase III protocol 9134
36. Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancer
37. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: A phase II study of the Lung Cancer Study Group
38. Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer
39. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: Report of a Cancer and Leukemia Group B phase II study
40. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group Phase II study 8805
41. Long-term survival after concurrent cisplatin/etoposide (PE) plus chest radiotherapy (RT) followed by surgery in bulky, stages IIIA (N2) and IIIB non-small cell lung cancer (NSCLC): 6-year outcomes from Southwest Oncology Group study 8805
42. Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lung
43. Postoperative complications after combined neoadjuvant treatment of lung cancer
44. Preoperative concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer
45. Surgical resection of stage IIIB non-small cell lung cancer after concomitant induction chemo-radiotherapy. Preliminary results of a pilot study
46. Chemoradiation therapy versus chemotherapy alone as a neoadjuvant treatment for stage III non-small cell lung cancer. Preliminary report of a phase III prospective randomized trial
47. Stage III non-small cell lung cancer (NSCLC): Short course multimodality treatment with accelerated fractionation radiation, concurrent cisplatin (DDP)/paclitaxel (TAX) chemotherapy and surgery
48. 3-D nonformal radio therapy in the sagittal plane for centrally located thoracic tumors